tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

PLRX Stock Latest News

Pliant Therapeutics Announces CBO Hans Hull’s Resignation
Company AnnouncementsPliant Therapeutics Announces CBO Hans Hull’s Resignation
23h ago
8K
PLRX
Pliant Therapeutics Settles Loan with Oxford Finance
PremiumCompany Announcements
Pliant Therapeutics Settles Loan with Oxford Finance
5d ago
8K
PLRX
Buy/Sell: Wall Street’s top 10 stock calls this week
PremiumThe Fly
Buy/Sell: Wall Street’s top 10 stock calls this week
15d ago
MU
AMD
Align downgraded, NetEase upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Align downgraded, NetEase upgraded: Wall Street’s top analyst calls
15d ago
ABT
MOS
Pliant Therapeutics downgraded to Underweight from Neutral at JPMorgan
PremiumThe Fly
Pliant Therapeutics downgraded to Underweight from Neutral at JPMorgan
15d ago
PLRX
Pliant Therapeutics Reports Q2 2025 Financial Results
PremiumCompany AnnouncementsPliant Therapeutics Reports Q2 2025 Financial Results
2M ago
PLRX
Pliant Therapeutics price target raised to $1.70 from $1.50 at Citi
Premium
The Fly
Pliant Therapeutics price target raised to $1.70 from $1.50 at Citi
3M ago
PLRX
Pliant Therapeutics price target lowered to $4 from $17 at Piper Sandler
Premium
The Fly
Pliant Therapeutics price target lowered to $4 from $17 at Piper Sandler
3M ago
PLRX
Pliant Therapeutics reports Q2 EPS (71c), consensus (68c)
PremiumThe Fly
Pliant Therapeutics reports Q2 EPS (71c), consensus (68c)
3M ago
PLRX
Pliant Therapeutics Approves Key Proposals at Annual Meeting
PremiumCompany Announcements
Pliant Therapeutics Approves Key Proposals at Annual Meeting
5M ago
8K
PLRX
Cautious Hold Rating on Pliant Therapeutics Amid Clinical and Financial Uncertainties
PremiumRatings
Cautious Hold Rating on Pliant Therapeutics Amid Clinical and Financial Uncertainties
6M ago
PLRX
Cautious Hold Rating for Pliant Therapeutics Amidst Strategic Restructuring and Drug Development Uncertainties
PremiumRatings
Cautious Hold Rating for Pliant Therapeutics Amidst Strategic Restructuring and Drug Development Uncertainties
6M ago
PLRX
PLRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsPLRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
6M ago
PLRX
Pliant Therapeutics Reports Q1 2025 Financial Results
Premium
Company Announcements
Pliant Therapeutics Reports Q1 2025 Financial Results
6M ago
PLRX
Pliant Therapeutics reports Q1 EPS (92c), consensus (62c)
Premium
The Fly
Pliant Therapeutics reports Q1 EPS (92c), consensus (62c)
6M ago
PLRX
Pliant Therapeutics reports Q1 EPS (92c), consensus (75c)
PremiumThe Fly
Pliant Therapeutics reports Q1 EPS (92c), consensus (75c)
6M ago
PLRX
Pliant Therapeutics to reduce workforce by 45%
PremiumThe Fly
Pliant Therapeutics to reduce workforce by 45%
6M ago
PLRX
Pliant Therapeutics Announces Major Workforce Reduction
PremiumCompany Announcements
Pliant Therapeutics Announces Major Workforce Reduction
6M ago
8K
PLRX
Hold Rating on Pliant Therapeutics Amid Uncertainty and Limited Data from Early-Stage Trials
PremiumRatings
Hold Rating on Pliant Therapeutics Amid Uncertainty and Limited Data from Early-Stage Trials
7M ago
PLRX
Neutral Rating on Pliant Therapeutics Amid Early Promising Data and Uncertainties
PremiumRatingsNeutral Rating on Pliant Therapeutics Amid Early Promising Data and Uncertainties
7M ago
PLRX
Pliant Therapeutics announces interim Phase 1 data from PLN-101095
Premium
The Fly
Pliant Therapeutics announces interim Phase 1 data from PLN-101095
7M ago
PLRX
Pliant Therapeutics Adopts Stockholder Rights Agreement
Premium
Company Announcements
Pliant Therapeutics Adopts Stockholder Rights Agreement
8M ago
8K
PLRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >